BANK OF MONTREAL /CAN/ - ACER THERAPEUTICS INC ownership

ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 38 filers reported holding ACER THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of ACER THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$5,000
-28.6%
1,331
-68.6%
0.00%
Q1 2020$7,000
-87.5%
4,233
-69.5%
0.00%
Q4 2019$56,000
-24.3%
13,870
-40.1%
0.00%
Q3 2019$74,000
+236.4%
23,141
+327.0%
0.00%
Q2 2019$22,000
-71.8%
5,419
+68.8%
0.00%
Q1 2019$78,000
+21.9%
3,2100.0%0.00%
Q4 2018$64,000
+30.6%
3,210
+100.0%
0.00%
Q3 2018$49,0001,6050.00%
Other shareholders
ACER THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Nantahala Capital Management 1,136,416$1,049,3670.10%
Anson Funds Management LP 129,795$119,8530.02%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 60,000$550.01%
Hudson Bay Capital Management LP 274,300$253,2890.00%
UBS Group AG 33$300.00%
RHUMBLINE ADVISERS 347$3200.00%
OSAIC HOLDINGS, INC. 200$1840.00%
WELLS FARGO & COMPANY/MN 132$1220.00%
NORTHERN TRUST CORP 22,231$20,5280.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ACER THERAPEUTICS INC shareholders